Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00000187Phase 2Completed
Phase 2 trial of ritanserin in cocaine dependence, sponsored by University of Pennsylvania. Primary endpoints: Cocaine use and Cocaine craving. Started Jul 1992; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00000187.